Rmm Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 5 Year, 3 Days
- Last Filing with ROC 31 Mar 2022
- Revenue 29.23%
(FY 2022)
- Profit 41.24%
(FY 2022)
- Ebitda 254.76%
(FY 2022)
- Net Worth -46.22%
(FY 2022)
- Total Assets 12.18%
(FY 2022)
About Rmm Healthcare India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rama Haleshappa, Muneer Pasha, and Jadapalli Manogaran serve as directors at the Company.
- CIN/LLPIN
U85110KA2020PTC131274
- Company No.
131274
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rmm Healthcare India Private Limited offer?
Rmm Healthcare India Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Concentrator, Wheel Chairs, Crutches and Walker, Wheelchairs, Hospital and Medical Furniture, Hospital Bed and Mattress, Medical Consultants & Clinics, Medical Consultancy Services.
Who are the key members and board of directors at Rmm Healthcare India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Haleshappa  | Director | 03-Jan-2020 | Current |
| Muneer Pasha | Director | 03-Jan-2020 | Current |
| Jadapalli Manogaran | Director | 03-Jan-2020 | Current |
Financial Performance of Rmm Healthcare India.
Rmm Healthcare India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.23% increase. The company also saw a substantial improvement in profitability, with a 41.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rmm Healthcare India?
In 2022, Rmm Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rmm Healthcare India?
Unlock and access historical data on people associated with Rmm Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rmm Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rmm Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
